Viewing data from:

MORPHINE SULFATE

ANDA

MORPHINE SULFATE | A203518 | TRIS PHARMA INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MORPHINE SULFATE

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 2 NDCs

Highest NADAC/Unit

$0.4096

per ml

Lowest NADAC/Unit

$0.3182

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
27808008201MORPHINE SULF 100 MG/5 ML CONC	$0.4096	ML	Generic	—	2026-08-19
27808008202MORPHINE SULF 100 MG/5 ML CONC	$0.3182	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$9.08

Highest Price

$39.10

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
27808-0082-01MORPHINE CONCENTRATED 20MG/ML SOLN,ORAL	$9.77	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
27808-0082-02MORPHINE CONCENTRATED 20MG/ML SOLN,ORAL	$39.10	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-1282-02MORPHINE CONCENTRATED 20MG/ML SOLN,ORAL	$37.04	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-1282-03MORPHINE CONCENTRATED 20MG/ML SOLN,ORAL	$9.08	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs6 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SPECGX LLCMORPHINE SULFATE

DMF 58571985

NORAMCO LLCMORPHINE SULFATE

DMF 69671987

VERANOVA LPMORPHINE SULFATE USP

DMF 215882008

NORAMCO LLCMORPHINE SULFATE, USP

DMF 293172015

PENICK CORPInactiveMORPHINE SULFATE

DMF 66801986

MACFARLAN SMITH LTDInactiveMORPHINE SULFATE

DMF 83281989

MALLINCKRODT INCInactiveMORPHINE SULFATE INJECTION USP

DMF 115291995

ELAN PHARMA LTDInactiveMORPHINE SULFATE

DMF 128081997

SIEGFRIED USA LLCInactiveMORPHINE SULFATE USP

DMF 196932006

CODY LABORATORIES INCInactiveMORPHINE SULFATE, USP

DMF 280402014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 19, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 10MG/5ML

0 patents0 exclusivities▴

SOLUTION;ORAL | Approved: May 12, 2015

No patent or exclusivity listings for this strength.

#002 — 100MG/5ML

0 patents0 exclusivities▾

SOLUTION;ORAL | Approved: May 12, 2015